학술논문
P1.01-119 Modified Lung Immune Prognostic Index (mLIPI) as a Predictive Tool of Nivolumab Outcomes in Advanced NSCLC Patients
Document Type
Abstract
Author
Source
In Journal of Thoracic Oncology October 2019 14(10) Supplement:S408-S409
Subject
Language
ISSN
1556-0864